FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Federico Garrido

Research Profile

Chemicals & Drugs

Genes & Molecular Sequences

Genes, MHC Class I

Physiology

Disorders

Anatomy

Living Beings

Procedures

Immunotherapy

Co-author Network

Publications

TOP 3
Pablo Sáenz-López; Fernando Vazquez; Rafael Carretero; Jose Manuel Cozar; Federico Garrido; Francisco Ruiz-Cabello
VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population.
Monica Bernal; Angel Concha; Annette Paschen; Francisco Ruiz-Cabello; Federico Garrido
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.
Rafael Carretero; Alyson M Engle; Federico Garrido; Hui Liu; Francesco M Marincola; Jennifer Reinboth; Ana I Rodriguez; Ena Wang; Maria L Ascierto; Francisco M Camacho; Teresa Cabrera
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Federico Garrido (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pablo Sáenz-López; Fernando Vazquez; Rafael Carretero; Jose Manuel Cozar; Federico Garrido; Francisco Ruiz-Cabello
VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population.
Human immunology 2013;74(1):98-103.
2012: Monica Bernal; Angel Concha; Annette Paschen; Francisco Ruiz-Cabello; Federico Garrido
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.
Cancer immunology, immunotherapy : CII 2012;61(9):1359-71.
2012: Rafael Carretero; Alyson M Engle; Federico Garrido; Hui Liu; Francesco M Marincola; Jennifer Reinboth; Ana I Rodriguez; Ena Wang; Maria L Ascierto; Francisco M Camacho; Teresa Cabrera
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.
International journal of cancer. Journal international du cancer 2012;131(2):387-95.
2012: Macarena Guirado; Jennifer Reinboth; Francisco Ruiz-Cabello; Pablo Saenz-Lopez; Jose Manuel Cozar; Federico Garrido; Hernani Gil; Rafael Carretero
Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.
Human immunology 2012;73(6):668-72.
2012: Mónica Bernal; Armando Blanco; Carlos Cano; Angel Concha; Fernando García-Alcalde; Federico Garrido; Francisco Ruiz-Cabello
Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape.
Cancer immunology, immunotherapy : CII 2012;61(6):803-16.
2012: Natalia Aptsiauri; Teresa Cabrera; Angel Garcia-Lora; Federico Garrido
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011.
Cancer immunology, immunotherapy : CII 2012;61(5):739-45.
2012: Ana Del Campo; Natalia Aptsiauri; J Carretero; Federico Garrido
Targeting HLA class I expression to increase tumor immunogenicity.
Tissue antigens 2012;79(3):147-54.
2012: Cristina Garrido; Federico Garrido; Laura Paco; Irene Romero; Julia Stefansky; Ignacio Algarra; Enrique Berruguilla; Antonia Collado; Angel Garcia-Lora
MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.
Carcinogenesis 2012;33(3):687-93.
2011: Cristina Garrido; Irene Romero; Ignacio Algarra; Enrique Berruguilla; Bárbara Cancela; Antonia Collado; Angel García-Lora; Federico Garrido
Immunotherapy eradicates metastases with reversible defects in MHC class I expression.
Cancer immunology, immunotherapy : CII 2011;60(9):1257-68.
2011: Rafael Carretero; Jose Manuel Cozar; Natalia Aptsiauri; Teresa Cabrera; Hernani Gil; Isabel Maleno; Pablo Saenz-Lopez; Federico Garrido
Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells.
International journal of cancer. Journal international du cancer 2011;129(4):839-46.
2011: Mónica Bernal; Angel Concha; Pablo Sáenz-López; Ana Isabel Rodríguez; Teresa Cabrera; Federico Garrido; Francisco Ruiz-Cabello
Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity.
Cancer immunology, immunotherapy : CII 2011;60(6):869-82.
2011: Isabel Maleno; Natalia Aptsiauri; Teresa Cabrera; Aurelia Gallego; Annette Paschen; Miguel A López-Nevot; Federico Garrido
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
Immunogenetics 2011;63(2):65-71.
2010: Ana Belén García-Ruano; Rosa Méndez; José María Romero; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Analysis of HLA-ABC locus-specific transcription in normal tissues.
Immunogenetics 2010;62(11-12):711-9.
2010: Federico Garrido; Teresa Cabrera; Natalia Aptsiauri
"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.
International journal of cancer. Journal international du cancer 2010;127(2):249-56.
2010: Pablo Sáenz-López; Rafael Carretero; Fernando Vazquez; Javier Martin; Elena Sánchez; Miguel Tallada; Federico Garrido; José Manuel Cózar; Francisco Ruiz-Cabello
Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
Human immunology 2010;71(3):309-13.
2010: P Sáenz-López; Cécile Gouttefangeas; J Hennenlotter; Angel Concha; Isabel Maleno; Francisco Ruiz-Cabello; José Manuel Cózar; Miguel Tallada; A Stenzl; H-G Rammensee; Federico Garrido; Teresa Cabrera
Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
Tissue antigens 2010;75(2):110-8.
2010: Cristina Garrido; Ignacio Algarra; Isabel Maleno; Julia Stefanski; Antonia Collado; Federico Garrido; Angel Garcia-Lora
Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity.
Cancer immunology, immunotherapy : CII 2010;59(1):13-26.
2009: Mónica Bernal; Pilar Garrido; Pilar Jiménez; Rafael Carretero; Manuel Almagro; Pilar López; Pilar Navarro; Federico Garrido; Francisco Ruiz-Cabello
Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.
Human immunology 2009;70(10):854-7.
2009: R Mendez; Natalia Aptsiauri; Ana Del Campo; Isabel Maleno; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido; Angel Garcia-Lora
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.
Cancer immunology, immunotherapy : CII 2009;58(9):1507-15.
2009: Ana Del Campo; Natalia Aptsiauri; Rosa Méndez; S Zinchenko; A Vales; A Paschen; S Ward; Francisco Ruiz-Cabello; G González-Aseguinolaza; Federico Garrido
Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy.
Scandinavian journal of immunology 2009;70(2):125-35.
2009: José María Romero; Pablo Sáenz-López; José Manuel Cózar; Rafael Carretero; Julia Canton; Fernando Vazquez; Angel Concha; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
Human immunology 2009;70(1):60-4.
2008: Natalia Aptsiauri; Rafael Carretero; Angel Garcia-Lora; Luis Miguel Real; Teresa Cabrera; Federico Garrido
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.
Cancer immunology, immunotherapy : CII 2008;57(11):1727-33.
2008: Rafael Carretero; José M Romero; Francisco Ruiz-Cabello; Isabel Maleno; Felix Rodriguez; Francisco M Camacho; Luis Miguel Real; Federico Garrido; Teresa Cabrera
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.
Immunogenetics 2008;60(8):439-47.
2008: Rosa Méndez; Teresa Rodríguez; Ana Del Campo; Eva Monge; Isabel Maleno; Natalia Aptsiauri; Pilar Jiménez; Susana Pedrinaci; Graham Pawelec; Francisco Ruiz-Cabello; Federico Garrido
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.
Cancer immunology, immunotherapy : CII 2008;57(5):719-29.
2008: Pablo Sáenz-López; Rafael Carretero; José Manuel Cózar; José María Romero; Julia Canton; José Ramón Vilchez; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.
BMC cancer 2008;8():382.
2008: Jose Manuel Cozar; Natalia Aptsiauri; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report.
Journal of medical case reports 2008;2():111.
2008: Eva Jiménez-Medina; Enrique Berruguilla; Irene Romero; Ignacio Algarra; Antonia Collado; Federico Garrido; Angel Garcia-Lora
The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis.
BMC cancer 2008;8():78.
2007: Laura Paco; Angel Garcia-Lora; Carlos Casares; Carmen Cabrera; Ignacio Algarra; Antonia Collado; Isabel Maleno; Federico Garrido; Miguel A Lopez-Nevot
Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response.
International journal of cancer. Journal international du cancer 2007;121(9):2023-30.
2007: Jose Manuel Cozar; José María Romero; Natalia Aptsiauri; Fernando Vazquez; Jose R Vilchez; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Human immunology 2007;68(8):698-704.
2007: Natalia Aptsiauri; Teresa Cabrera; Graham Pawelec; Cécile Gouttefangeas; Evelyna Derhovanessian; Federico Garrido; Angel Garcia-Lora
International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.
Cancer immunology, immunotherapy : CII 2007;56(8):1311-22.
2007: Teresa Cabrera; Ester Lara; José María Romero; Isabel Maleno; Luis Miguel Real; Francisco Ruiz-Cabello; Pedro Valero; Francisco M Camacho; Federico Garrido
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.
Cancer immunology, immunotherapy : CII 2007;56(5):709-17.
2007: Teresa Cabrera; Isabel Maleno; Antonia Collado; Miguel A Lopez-Nevot; Brian Tait; Federico Garrido
Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.
Tissue antigens 2007;69 Suppl 1():264-8.
2007: T Rodriguez; Natalia Aptsiauri; Rosa Méndez; Pilar Jimenez; Francisco Ruiz-Cabello; Federico Garrido
Different mechanisms can lead to the same altered HLA class I phenotype in tumors.
Tissue antigens 2007;69 Suppl 1():259-63.
2007: Derek Middleton; Jose R Vilchez; Teresa Cabrera; Ashley Meenagh; Fionnuala Williams; Iris A Halfpenny; Isabel Maleno; Francisco Ruiz-Cabello; Miguel A Lopez-Nevot; Federico Garrido
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours.
Tissue antigens 2007;69(3):220-6.
2007: Teresa Rodríguez; Rosa Méndez; Ana Del Campo; Natalia Aptsiauri; J Martín; G Orozco; Graham Pawelec; Dirk Schadendorf; Francisco Ruiz-Cabello; Federico Garrido
Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Immunogenetics 2007;59(2):123-33.
2007: Natalia Aptsiauri; Teresa Cabrera; Rosa Mendez; Angel Garcia-Lora; Francisco Ruiz-Cabello; Federico Garrido
Role of altered expression of HLA class I molecules in cancer progression.
Advances in experimental medicine and biology 2007;601():123-31.
2007: Teresa Rodríguez; Rosa Méndez; Ana Del Campo; Pilar Jiménez; Natalia Aptsiauri; Federico Garrido; Francisco Ruiz-Cabello
Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
BMC cancer 2007;7():34.
2007: Natalia Aptsiauri; Teresa Cabrera; Angel Garcia-Lora; Miguel A Lopez-Nevot; Francisco Ruiz-Cabello; Federico Garrido
MHC class I antigens and immune surveillance in transformed cells.
International review of cytology 2007;256():139-89.
2007: Rosa Méndez; Francisco Ruiz-Cabello; Teresa Rodríguez; Ana Del Campo; Annette Paschen; Dirk Schadendorf; Federico Garrido
Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy.
Cancer immunology, immunotherapy : CII 2007;56(1):88-94.
2006: José María Romero; Natalia Aptsiauri; F Vazquez; Jose Manuel Cozar; Julia Canton; Teresa Cabrera; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Tissue antigens 2006;68(4):303-10.
2006: Isabel Maleno; José María Romero; Teresa Cabrera; Laura Paco; Natalia Aptsiauri; Jose Manuel Cozar; Miguel Tallada; Miguel A López-Nevot; Federico Garrido
LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Immunogenetics 2006;58(7):503-10.
2006: Eva Jiménez-Medina; Angel Garcia-Lora; Laura Paco; Ignacio Algarra; Antonia Collado; Federico Garrido
A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation.
BMC cancer 2006;6():119.
2005: José Manuel Cózar; Julia Canton; Miguel Tallada; Angel Concha; Teresa Cabrera; Federico Garrido; Francisco Ruiz-Cabello Osuna
Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
Cancer immunology, immunotherapy : CII 2005;54(9):858-66.
2005: Rocío Alvarado-Guerri; Carmen Cabrera; Federico Garrido; Miguel A López-Nevot
TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an eastern Andalusian population.
Human immunology 2005;66(8):921-30.
2005: Eva Jiménez; Angel Garcia-Lora; Marisol Martinez; Federico Garrido
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells.
Cancer immunology, immunotherapy : CII 2005;54(4):395-9.
2005: José María Romero; Pilar Jiménez; Teresa Cabrera; José Manuel Cózar; Susana Pedrinaci; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
International journal of cancer. Journal international du cancer 2005;113(4):605-10.
2005: Carmen Cabrera; Miguel A López-Nevot; Pilar Jiménez; Federico Garrido
Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors.
International journal of cancer. Journal international du cancer 2005;113(4):611-8.
2005: Teresa Rodriguez; Rosa Méndez; Chrissy H Roberts; Francisco Ruiz-Cabello; I Anthony Dodi; Miguel A López-Nevot; Laura Paco; Isabel Maleno; Steven G E Marsh; Graham Pawelec; Federico Garrido
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Cancer immunology, immunotherapy : CII 2005;54(2):141-8.
2004: Ignacio Algarra; Angel García-Lora; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Cancer immunology, immunotherapy : CII 2004;53(10):904-10.
2004: Isabel Maleno; Carmen Cabrera; Teresa Cabrera; Laura Paco; Miguel A López-Nevot; Antonia Collado; Antonio Ferrón; Federico Garrido
Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Immunogenetics 2004;56(4):244-53.
2004: Carmen Tormos; F Javier Chaves; Maria José Garcia; Federico Garrido; Ramiro Jover; Jose-Enrique O'Connor; Antonio Iradi; Ana Oltra; Maria R Oliva; Guillermo T Sáez
Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells.
Cancer letters 2004;208(1):103-13.
2004: C M Cabrera; Pilar Jiménez; Angel Concha; Federico Garrido; Francisco Ruiz-Cabello
Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
Tissue antigens 2004;63(5):446-52.
2004: Isabel Maleno; Miguel A Lopez-Nevot; Barbara Seliger; Federico Garrido
Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.
International journal of cancer. Journal international du cancer 2004;109(4):636-8.
2003: Teresa Cabrera; Isabel Maleno; Miguel A Lopez-Nevot; Maximino Redondo; Maria Angustias Fernandez; Antonia Collado; Federico Garrido
High frequency of HLA-B44 allelic losses in human solid tumors.
Human immunology 2003;64(10):941-50.
2003: Teresa Cabrera; G Pedrajas; Jose Manuel Cozar; A Garrido; J Vicente; Miguel Tallada; Federico Garrido
HLA class I expression in bladder carcinomas.
Tissue antigens 2003;62(4):324-7.
2003: Angel Garcia-Lora; Marisol Martinez; Ignacio Algarra; José Juan Gaforio; Federico Garrido
MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
International journal of cancer. Journal international du cancer 2003;106(4):521-7.
2003: Angel García-Lora; Ignacio Algarra; Antonia Collado; Federico Garrido
Tumour immunology, vaccination and escape strategies.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2003;30(3):177-83.
2003: Angel Garcia-Lora; Ignacio Algarra; Federico Garrido
MHC class I antigens, immune surveillance, and tumor immune escape.
Journal of cellular physiology 2003;195(3):346-55.
2003: C M Cabrera; Pilar Jiménez; Teresa Cabrera; C Esparza; Francisco Ruiz-Cabello; Federico Garrido
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Tissue antigens 2003;61(3):211-9.
2003: Annette Paschen; Rosa Méndez; Pilar Jimenez; Antje Sucker; Francisco Ruiz-Cabello; Mingxia Song; Federico Garrido; Dirk Schadendorf
Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
International journal of cancer. Journal international du cancer 2003;103(6):759-67.
2003: Rosario Marín; Francisco Ruiz-Cabello; Susana Pedrinaci; Rosa Méndez; Pilar Jiménez; Daniel E Geraghty; Federico Garrido
Analysis of HLA-E expression in human tumors.
Immunogenetics 2003;54(11):767-75.
2003: Angel García-Lora; Marisol Martinez; Susana Pedrinaci; Federico Garrido
Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line.
Cancer immunology, immunotherapy : CII 2003;52(1):59-64.
2003: Teresa Cabrera; Miguel A López-Nevot; José Juan Gaforio; Francisco Ruiz-Cabello; Federico Garrido
Analysis of HLA expression in human tumor tissues.
Cancer immunology, immunotherapy : CII 2003;52(1):1-9.
2002: Isabel Maleno; Miguel A López-Nevot; Teresa Cabrera; José Salinero; Federico Garrido
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Cancer immunology, immunotherapy : CII 2002;51(7):389-96.
2002: Francisco Ruiz-Cabello; Teresa Cabrera; Miguel A Lopez-Nevot; Federico Garrido
Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy.
Seminars in cancer biology 2002;12(1):15-24.
2001: A Serrano; Silvia Tanzarella; Ilaria Lionello; R Mendez; Catia Traversari; Francisco Ruiz-Cabello; Federico Garrido
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.
International journal of cancer. Journal international du cancer 2001;94(2):243-51.
2001: Pilar Jiménez; Teresa Cabrera; R Méndez; C Esparza; Jose Manuel Cozar; Miguel Tallada; Miguel A López-Nevot; Francisco Ruiz-Cabello; Federico Garrido
A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*0301 allele in a prostate carcinoma cell line.
Immunogenetics 2001;53(7):606-10.
2001: Maria R Oliva; Antonio Iradi; Federico Garrido; M Ramos; Ana Oltra; Pilar Muñiz; Guillermo T Sáez
Oxidative stress induces the expression of the major histocompatibility complex in murine tumor cells.
Free radical research 2001;35(2):119-28.
2001: R Mendez; A Serrano; E Jäger; Isabel Maleno; Francisco Ruiz-Cabello; A Knuth; Federico Garrido
Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy.
Tissue antigens 2001;57(6):508-19.
2001: Angel García-Lora; Susana Pedrinaci; Federico Garrido
Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line.
Cancer immunology, immunotherapy : CII 2001;50(4):191-8.
2001: Luis Ramal; Rosario de Pablo; M J Guadix; J Sánchez; A Garrido; Federico Garrido; Juan Jiménez-Alonso; Miguel A López-Nevot
HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain.
Tissue antigens 2001;57(2):138-43.
2001: Federico Garrido; I Algarra
MHC antigens and tumor escape from immune surveillance.
Advances in cancer research 2001;83():117-58.
2001: Luis Miguel Real; Pilar Jimenez; Alexei F Kirkin; A Serrano; A García; Julia Cantón; Jesper Zeuthen; Federico Garrido; Francisco Ruiz-Cabello
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient.
Cancer immunology, immunotherapy : CII 2001;49(11):621-8.
2001: Angel Garcia-Lora; Ignacio Algarra; José Juan Gaforio; Francisco Ruiz-Cabello; Federico Garrido
Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.
International journal of cancer. Journal international du cancer 2001;91(1):109-19.
2000: Luis Ramal; Isabel Maleno; Teresa Cabrera; Antonia Collado; A Ferron; Miguel A Lopez-Nevot; Federico Garrido
Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
Human immunology 2000;61(10):1001-12.
2000: A Serrano; CS Brady; Pilar Jimenez; Margaret Duggan-Keen; R Mendez; Peter L Stern; Federico Garrido; Francisco Ruiz-Cabello
A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells.
Immunogenetics 2000;51(12):1047-52.
2000: Luis Ramal; M Feenstra; Albert van der Zwan; Antonia Collado; Miguel A Lopez-Nevot; Marcel G J Tilanus; Federico Garrido
Criteria to define HLA haplotype loss in human solid tumors.
Tissue antigens 2000;55(5):443-8.
2000: CS Brady; J S Bartholomew; Deborah J Burt; Margaret Duggan-Keen; S Glenville; N Telford; A M Little; Judith A Davidson; Pilar Jimenez; Francisco Ruiz-Cabello; Federico Garrido; Peter L Stern
Multiple mechanisms underlie HLA dysregulation in cervical cancer.
Tissue antigens 2000;55(5):401-11.
2000: Teresa Cabrera; J Salinero; Maria Angustias Fernandez; A Garrido; J Esquivias; Federico Garrido
High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Human immunology 2000;61(5):499-506.
2000: Pilar Jimenez; Julia Cantón; Angel Concha; Teresa Cabrera; M Fernández; Luis Miguel Real; A García; A Serrano; Federico Garrido; Francisco Ruiz-Cabello
Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Cancer immunology, immunotherapy : CII 2000;48(12):684-90.
2000: M A Fernández; Francisco Ruiz-Cabello; Maria R Oliva; Teresa Cabrera; Pilar Jimenez; Miguel A López-Nevot; Federico Garrido
Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors.
International journal of clinical & laboratory research 2000;30(2):87-92.
2000: Ignacio Algarra; Teresa Cabrera; Federico Garrido
The HLA crossroad in tumor immunology.
Human immunology 2000;61(1):65-73.
1999: Pilar Jiménez; Julia Cantón; Antonia Collado; Teresa Cabrera; A Serrano; Luis Miguel Real; A García; Francisco Ruiz-Cabello; Federico Garrido
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors.
International journal of cancer. Journal international du cancer 1999;83(1):91-7.
1999: Luis Miguel Real; Teresa Cabrera; Julia Canton; R Oliva; Francisco Ruiz-Cabello; Federico Garrido
Looking for HLA-G expression in human tumours.
Journal of reproductive immunology 1999;43(2):263-73.
1999: B Pérez; R Benitez; M A Fernández; Maria R Oliva; J L Soto; S Serrano; Miguel A López-Nevot; Federico Garrido
A new beta 2 microglobulin mutation found in a melanoma tumor cell line.
Tissue antigens 1999;53(6):569-72.
1999: Luis Miguel Real; Teresa Cabrera; Antonia Collado; Pilar Jimenez; A Garcia; Francisco Ruiz-Cabello; Federico Garrido
Expression of HLA G in human tumors is not a frequent event.
International journal of cancer. Journal international du cancer 1999;81(4):512-8.
1999: Ignacio Algarra; José Juan Gaforio; Teresa Cabrera; Antonia Collado; Federico Garrido
The biological consequences of altered MHC class I expression in tumours.
Journal of biological regulators and homeostatic agents 1999;13(2):90-6.
1999: Ignacio Algarra; Antonia Collado; Angel Garcia-Lora; Federico Garrido
Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors.
Journal of experimental & clinical cancer research : CR 1999;18(1):39-46.
1999: A García; A Serrano; Eduardo Abril; Pilar Jimenez; Luis Miguel Real; Julia Cantón; Federico Garrido; Francisco Ruiz-Cabello
Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression.
Experimental hematology 1999;27(2):353-64.
1999: Susana Pedrinaci; Ignacio Algarra; Angel Garcia-Lora; José Juan Gaforio; M Perez; Federico Garrido
Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma.
International journal of clinical & laboratory research 1999;29(4):166-73.
1999: Susana Pedrinaci; Ignacio Algarra; Federico Garrido
Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line.
International journal of clinical & laboratory research 1999;29(4):135-40.
1998: R Benitez; Danièle Godelaine; Miguel A Lopez-Nevot; Francis Brasseur; P Jiménez; M Marchand; Maria R Oliva; Nicolas van Baren; Teresa Cabrera; G Andry; C Landry; Francisco Ruiz-Cabello; Thierry Boon; Federico Garrido
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.
Tissue antigens 1998;52(6):520-9.
1998: Eduardo Abril; Luis Miguel Real; A Serrano; Pilar Jimenez; A García; Julia Canton; I Trigo; Federico Garrido; Francisco Ruiz-Cabello
Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line.
Cancer immunology, immunotherapy : CII 1998;47(2):113-20.
1998: Pilar Jiménez; Julia Cantón; Angel Concha; L M Torres; Eduardo Abril; Luis Miguel Real; A García; Federico Garrido; Francisco Ruiz-Cabello
Microsatellite instability in cervical intraepithelial neoplasia.
Journal of experimental & clinical cancer research : CR 1998;17(3):361-6.
1998: Teresa Cabrera; Antonia Collado; Maria Angustias Fernandez; A Ferron; J Sancho; Francisco Ruiz-Cabello; Federico Garrido
High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.
Tissue antigens 1998;52(2):114-23.
1998: Luis Miguel Real; Pilar Jimenez; Julia Cantón; Alexei F Kirkin; A García; Eduardo Abril; Jesper Zeuthen; Francisco Ruiz-Cabello; Federico Garrido
In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele.
International journal of cancer. Journal international du cancer 1998;75(2):317-23.
1998: Ignacio Algarra; M Perez; María-José Serrano; Federico Garrido; José Juan Gaforio
c-K-ras overexpression is characteristic for metastases derived from a methylcholanthrene-induced fibrosarcoma.
Invasion & metastasis 1998;18(5-6):261-70.
1997: Ignacio Algarra; Antonia Collado; Federico Garrido
Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Journal of experimental & clinical cancer research : CR 1997;16(4):373-80.
1997: Federico Garrido; Francisco Ruiz-Cabello; Teresa Cabrera; JJ Pérez-Villar; M López-Botet; Margaret Duggan-Keen; Peter L Stern
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
Immunology today 1997;18(2):89-95.
1997: Ignacio Algarra; Antonia Collado; Federico Garrido
Altered MHC class I antigens in tumors.
International journal of clinical & laboratory research 1997;27(2):95-102.
1996: Francisco Esteban; M Redondo; M Delgado; Federico Garrido; Francisco Ruiz-Cabello
MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.
British journal of cancer 1996;74(11):1801-4.
1996: A Serrano; A García; Eduardo Abril; Federico Garrido; Francisco Ruiz-Cabello
Methylated CpG points identified within MAGE-1 promoter are involved in gene repression.
International journal of cancer. Journal international du cancer 1996;68(4):464-70.
1996: Teresa Cabrera; M Angustias Fernandez; A Sierra; A Garrido; A Herruzo; Agustín Escobedo; Angels Fabra; Federico Garrido
High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
Human immunology 1996;50(2):127-34.
1996: Eduardo Abril; R E Mendez; A García; A Serrano; Teresa Cabrera; Federico Garrido; Francisco Ruiz-Cabello
Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon.
Tissue antigens 1996;47(5):391-8.
1996: M J Torres; Francisco Ruiz-Cabello; A Skoudy; G Berrozpe; Pilar Jimenez; A Serrano; Francisco X Real; Federico Garrido
Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.
Tissue antigens 1996;47(5):372-81.
1996: Ignacio Algarra; A González; M Pérez; José Juan Gaforio; Federico Garrido
Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours.
Clinical and experimental immunology 1996;103(3):499-505.
1995: A Serrano; A Garcia; Eduardo Abril; Federico Garrido; Francisco Ruiz-Cabello
Differential MAGE-1 gene expression in two variants of an erythroleukemic cell line (K562).
Immunobiology 1995;194(4-5):449-56.
1995: Angel Concha; Francisco Ruiz-Cabello; Teresa Cabrera; Francisco F Nogales; Antonia Collado; Federico Garrido
Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1995;22(4):299-310.
1995: T Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Biological implications of HLA-DR expression in tumours.
Scandinavian journal of immunology 1995;41(4):398-406.
1995: Federico Garrido; Teresa Cabrera; M A Lopez-Nevot; Francisco Ruiz-Cabello
HLA class I antigens in human tumors.
Advances in cancer research 1995;67():155-95.
1994: Ignacio Algarra; M Pérez; José Juan Gaforio; F Gasca; Federico Garrido
In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones.
Clinical & experimental metastasis 1994;12(1):31-6.
1993: Ignacio Algarra; M Pérez; P Höglund; José Juan Gaforio; Hans-Gustaf Ljunggren; Federico Garrido
Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue.
International journal of cancer. Journal international du cancer 1993;54(3):518-23.
1993: L M Torres; Teresa Cabrera; Angel Concha; Maria R Oliva; Francisco Ruiz-Cabello; Federico Garrido
HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Tissue antigens 1993;41(2):65-71.
1992: José Prados; J E Fernández; Federico Garrido; Luis Alvarez; R Hidalgo; M A Muros; Antonia Aránega
Expression of alpha-tropomyosin during cardiac development in the chick embryo.
The Anatomical record 1992;234(3):301-9.
1992: Teresa Cabrera; V Garrido; Angel Concha; J Martín; J Esquivias; Maria R Oliva; Francisco Ruiz-Cabello; S Serrano; Federico Garrido
HLA molecules in basal cell carcinoma of the skin.
Immunobiology 1992;185(5):440-52.
1992: M J Mialdea; J Martin; José Juan Gaforio; Ignacio Algarra; M Pérez; A Gonzalez; Hans-Gustaf Ljunggren; Federico Garrido
Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma.
International journal of cancer. Journal international du cancer 1992;52(1):153-8.
1991: José Juan Gaforio; M Pérez; Ignacio Algarra; M J Mialdea; Hans-Gustaf Ljunggren; Federico Garrido
Differential mRNA levels of c-myc, c-fos and MHC class I in several clones of a murine fibrosarcoma.
International journal of cancer. Journal international du cancer 1991;49(6):906-10.
1991: Maximino Redondo; Angel Concha; R Oldiviela; A Cueto; A Gonzalez; Federico Garrido; Francisco Ruiz-Cabello
Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Cancer research 1991;51(18):4948-54.
1991: Antonia Collado; A de Andres; E Cañadas; Francisco Ruiz-Cabello; O Gomez; S Pedrinaci; Federico Garrido
Characterization of CD44 antigen during lymphoid ontogeny.
Immunobiology 1991;183(1-2):1-11.
1991: J E Fernández; Angel Concha; Antonia Aránega; Francisco Ruiz-Cabello; Teresa Cabrera; Federico Garrido
HLA class I and II expression in rhabdomyosarcomas.
Immunobiology 1991;182(5):440-8.
1991: Teresa Cabrera; Angel Concha; Francisco Ruiz-Cabello; Federico Garrido
Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours.
Scandinavian journal of immunology 1991;34(2):147-52.
1991: Francisco Ruiz-Cabello; E Klein; Federico Garrido
MHC antigens on human tumors.
Immunology letters 1991;29(3):181-9.
1991: Maximino Redondo; Francisco Ruiz-Cabello; Angel Concha; Teresa Cabrera; M Pérez-Ayala; Maria R Oliva; Federico Garrido
Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Cancer research 1991;51(9):2463-8.
1991: Angel Concha; Francisco Esteban; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Seminars in cancer biology 1991;2(1):47-54.
1991: Federico Garrido; Francisco Ruiz-Cabello
MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Seminars in cancer biology 1991;2(1):3-10.
1991: Ignacio Algarra; José Juan Gaforio; A Garrido; M J Mialdea; M Pérez; Federico Garrido
Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():73-81.
1991: Angel Concha; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Can the HLA phenotype be used as a prognostic factor in breast carcinomas?
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():146-54.
1991: Francisco Ruiz-Cabello; M Perez-Ayala; O Gomez; Maximino Redondo; Angel Concha; Teresa Cabrera; Federico Garrido
Molecular analysis of MHC-class-I alterations in human tumor cell lines.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():123-30.
1991: Javier Martín; D Almeida; M J Mialdea; M Rodriguez; L Mataran; Federico Garrido
DNA-RFLP analysis and genotyping of HLA-DR alleles in the south of Spain.
Experimental and clinical immunogenetics 1991;8(2):119-20.
1990: Francisco Esteban; Angel Concha; M Delgado; M Pérez-Ayala; Francisco Ruiz-Cabello; Federico Garrido
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
British journal of cancer 1990;62(6):1047-51.
1990: Francisco Esteban; Angel Concha; M Delgado; Francisco Ruiz-Cabello; Federico Garrido
[Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].
Acta otorrinolaringológica española 1990;41(6):359-68.
1990: Francisco Esteban; Francisco Ruiz-Cabello; Angel Concha; M Perez Ayala; M Delgado; Federico Garrido
Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx.
Cancer 1990;66(7):1493-8.
1990: Maria R Oliva; Teresa Cabrera; J Esquivias; M Perez-Ayala; Maximino Redondo; Francisco Ruiz-Cabello; Federico Garrido
K-ras mutations (codon 12) are not involved in down-regulation of MHC class-I genes in colon carcinomas.
International journal of cancer. Journal international du cancer 1990;46(3):426-31.
1990: Francisco Esteban; Angel Concha; Francisco Ruiz-Cabello; Federico Garrido
[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
Acta otorrinolaringológica española 1990;41(5):297-303.
1990: M Pérez; Ignacio Algarra; Hans-Gustaf Ljunggren; A Caballero; M J Mialdea; José Juan Gaforio; G Klein; Klas Kärre; Federico Garrido
A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.
International journal of cancer. Journal international du cancer 1990;46(2):258-61.
1990: M Pérez-Ayala; Francisco Ruiz-Cabello; Francisco Esteban; Angel Concha; Maximino Redondo; Maria R Oliva; Teresa Cabrera; Federico Garrido
Presence of HPV 16 sequences in laryngeal carcinomas.
International journal of cancer. Journal international du cancer 1990;46(1):8-11.
1990: Francisco Esteban; Francisco Ruiz-Cabello; Angel Concha; M Pérez-Ayala; J A Sánchez-Rozas; Federico Garrido
HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.
Clinical & experimental metastasis 1990;8(4):319-28.
1990: S Pedrinaci; Francisco Ruiz-Cabello; O Gomez; Antonia Collado; Federico Garrido
Protein kinase C-mediated regulation of the expression of CD14 and CD11/CD18 in U937 cells.
International journal of cancer. Journal international du cancer 1990;45(2):294-8.
1990: J Gutierrez; Francisco Ruiz-Cabello; M A López Nevot; Teresa Cabrera; J Esquivias; Federico Garrido
Class II HLA antigen expression in familial polyposis coli is related to the degree of dysplasia.
Immunobiology 1990;180(2-3):138-48.
1990: M A Lopez Nevot; L Cardona; E Doblaré; C Muñoz; Francisco Ruiz-Cabello; Federico Garrido
The monoclonal antibody GRC1 produced against human cornea recognizes a common determinant of collagen.
Investigative ophthalmology & visual science 1990;31(2):290-3.
1989: Ignacio Algarra; C Ohlén; M Perez; Hans-Gustaf Ljunggren; G Klein; Federico Garrido; Klas Kärre
NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma.
International journal of cancer. Journal international du cancer 1989;44(4):675-80.
1989: A Ferron; M Perez-Ayala; Angel Concha; Teresa Cabrera; Maximino Redondo; Maria R Oliva; Francisco Ruiz-Cabello; Federico Garrido
MHC class I and II antigens on gastric carcinomas and autologous mucosa.
Journal of immunogenetics 1989;16(4-5):413-23.
1989: A Caballero; A Garrido; Ignacio Algarra; M Perez; Federico Garrido
Generation of syngeneic anti-tumour double negative cells (CD4- CD8-), with cytotoxic activity against clones of different MHC class I expression.
Journal of immunogenetics 1989;16(4-5):321-8.
1989: Francisco Esteban; Angel Concha; C Huelin; M Pérez-Ayala; S Pedrinaci; Francisco Ruiz-Cabello; Federico Garrido
Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
International journal of cancer. Journal international du cancer 1989;43(3):436-42.
1989: M A López-Nevot; Francisco Esteban; A Ferrón; J Gutiérrez; Maria R Oliva; C Romero; C Huelin; Francisco Ruiz-Cabello; Federico Garrido
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
British journal of cancer 1989;59(2):221-6.
1989: S Pedrinaci; C Huelin; M Patarroyo; Francisco Ruiz-Cabello; Federico Garrido
Studies on CD11a and CD18 molecules with two new monoclonal antibodies: differential myelomonocytic antigen expression of PMA treated HL60 and U937 cell lines.
Hybridoma 1989;8(1):13-23.
1989: Francisco Ruiz-Cabello; C Huelin; S Pedrinaci; M A Lopez Nevot; Federico Garrido
Different CD45 and CD45R epitopes involved in T cell proliferation and NK cytotoxicity.
Hybridoma 1989;8(1):1-11.
1989: M Pérez; A Garrido; Ignacio Algarra; A Caballero; C Delgado; M D Collado; E Fernández-Cruz; Federico Garrido
H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Experimental and clinical immunogenetics 1989;6(3):204-18.
1988: C Huelin; M Gonzalez; S Pedrinaci; B de la Higuera; M A Piris; J San Miguel; Francisco Ruiz-Cabello; Federico Garrido
Distribution of the CD45R antigen in the maturation of lymphoid and myeloid series: the CD45R negative phenotype is a constant finding in T CD4 positive lymphoproliferative disorders.
British journal of haematology 1988;69(2):173-9.
1988: M A López-Nevot; E Garcia; C Romero; Maria R Oliva; S Serrano; Federico Garrido
Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.
Experimental and clinical immunogenetics 1988;5(4):203-12.
1987: E Cañadas; M de Andres; B de la Higuera; F J Muñoz; S Pedrinaci; Francisco Ruiz-Cabello; Federico Garrido
Study of the monoclonal antibodies against blood group B and A + B (group 2) of the First International Workshop. Pattern of reaction with colon carcinomas.
Revue française de transfusion et immuno-hématologie 1987;30(5):609-11.
1987: M de Andres; E Cañadas; F J Muñoz; B de la Higuera; S Pedrinaci; Francisco Ruiz-Cabello; Federico Garrido
Study of the monoclonal antibodies against blood group A (group N. 1) of the First International Workshop. Pattern of reaction with normal colon mucosa and colon carcinomas.
Revue française de transfusion et immuno-hématologie 1987;30(5):485-8.
1987: Francisco Ruiz-Cabello; B de la Higuera; M A López Nevot; C Huelin; J M Conejo; Federico Garrido
A monoclonal antibody, GR7A4, reacting with the T10 antigen.
Hybridoma 1987;6(3):275-84.
1987: J Gutierrez; M A López-Nevot; Teresa Cabrera; R Oliva; J Esquivias; Francisco Ruiz-Cabello; Federico Garrido
Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.
Experimental and clinical immunogenetics 1987;4(3):144-52.
1987: F Ruiz-Cabello; M A López Nevot; A Garrido; Federico Garrido
A study of GRM1 monoclonal antibody that reacts with natural killer cells and granulocytes.
Natural immunity and cell growth regulation 1987;6(2):99-108.
1987: M de Andrés; Francisco Ruiz-Cabello; M A López Nevot; C Huelin; J M Conejo; A Cabrera; Federico Garrido
[Presentation of 2 new anti-blood group A monoclonal antibodies: study and characterization].
Sangre 1987;32(1):1-5.
1986: C Delgado; A Garrido; M Pérez; M L Garrido; Ignacio Algarra; Federico Garrido
Characterization of the syngeneic anti-tumour response against the GR9 tumour with the production of isoantisera and monoclonal antibodies.
Journal of immunogenetics 1986;13(2-3):169-77.
1986: M L Garrido; M Pérez; C Delgado; J Rojano; Ignacio Algarra; A Garrido; Federico Garrido
Immunogenicity of H-2 positive and H-2 negative clones of a mouse tumour, GR9.
Journal of immunogenetics 1986;13(2-3):159-67.
1986: M A Lopez Nevot; E Garcia; E Pareja; F J Bonal; J Martin; Francisco Ruiz-Cabello; S Serrano; Federico Garrido
Differential expression of HLA class I and II antigens in primary and metastatic melanomas.
Journal of immunogenetics 1986;13(2-3):219-27.
1986: M Pérez; Teresa Cabrera; M A Lopez Nevot; M Gomez; F Peran; Francisco Ruiz-Cabello; Federico Garrido
Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma.
Journal of immunogenetics 1986;13(2-3):247-53.
1986: F J Bonal; E Pareja; J Martin; C Romero; Federico Garrido
Repression of class I H-2K, H-2D antigens on GR9 methylcholanthrene-induced tumour cell clones is related to the level of DNA methylation.
Journal of immunogenetics 1986;13(2-3):179-86.
1986: T Cabrera; Francisco Ruiz-Cabello; M A Lopez; B de la Higuera; M Sanchez; Federico Garrido
Characterization of monoclonal antibodies directed against HLA class II molecules.
Hybridoma 1986;5(3):191-7.
1986: M A López Nevot; Francisco Ruiz-Cabello; C Huelin; A Cabrera; Federico Garrido
[A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia].
Sangre 1986;31(6):751-8.
1986: A Garrido; M Pérez; C Delgado; M L Garrido; J Rojano; Ignacio Algarra; Federico Garrido
Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor.
Experimental and clinical immunogenetics 1986;3(2):98-110.
1985: M Gómez Morales; M A De Andrés; M L Garrido; C Delgado; A Cabrera; Federico Garrido
[Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies].
Sangre 1985;30(3):348-54.
1985: E Pareja; F J Bonal; P Paule; D Salvatierra; Federico Garrido
HLA antigens in brucellosis.
Experimental and clinical immunogenetics 1985;2(1):1-3.
1985: M Gomez-Morales; Francisco Ruiz-Cabello; M A López; A Collado; T Cabrera; J San Miguel; Federico Garrido
A monoclonal antibody GR2110 reactive with a P24 antigen present in a subgroup of acute lymphoid leukemias.
Hybridoma 1985;4(4):369-78.
1985: Francisco Ruiz-Cabello; M González; M A López; A Cabrera; J San Miguel; Federico Garrido
[A new monoclonal antibody produced against a human leukemia which recognizes class II HLA antigens].
Sangre 1985;30(2):190-6.